Viral Vector Production Platform

Rapid Path to First in Human with greater predictability.

To alleviate the industry bottleneck for Viral Vector Supply, we invested significant resources to develop a production platform that delivers QC tested and released GMP lots.

Viral Vector Production Platform Overview

  • Ideal for Lenti, AAV, and Adenovirus Viral Vectors
  • Greater Supply Chain Control – materials are in stock, assembled, and released
  • Accelerated program start – plug and play if you meet defined criteria
  • Elements include raw materials, cell line, MCB/WCB, plasmids, upstream/downstream process, analytics, batch records, SOP’s, trained staff
  • Closed Adherent Production System utilizing Corning HyperStacks reduces contamination risks
  • Dedicated Suite Model: Upstream and Downstream performed in the same suite
  • Up to 250 L Yields (Gene of Interest Vector Dependent)
  • Integrated in-process and release testing performed onsite

Request a quote

Speak to our technical team today.

Platform, Hybrid or Custom? Take this quiz to find out if your Gene of Interest is compatible with our platform.

Welcome to your Vector Production Timeline Planner for Clinical Trials

Email Address
Name
Company

What viral vector are you using as a therapeutic vehicle?

Will you be providing your own plasmids?

Would you utilize our WuXi Adherent HEK293T (WAHT) MCB/WCB?

Does your process utilize any proprietary, media, reagents or consumables?

What is your GMP Scale? (bulk only)

What are your fill requirements?

Are you willing to utilize our platform testing plan as is?

Do you require STAT Testing?



Speak with our experts

Learn more about our platform.

Browse additional services